Using AI to predict cardiometabolic risk in Asian Indians with Type 2 diabetes
Use of Artificial Intelligence and Machine Learning in Cardiovascular Risk Prediction in Urban Asian Indians
This study is trying to see if using AI can help predict health risks in Asian Indians with Type 2 diabetes by looking at their health and lifestyle information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 25 Years to 80 Years |
| Sex | All |
| Sponsor | Diabetes Foundation, India Academic / other |
| Locations | 1 site (New Delhi, Delhi) |
| Trial ID | NCT05939869 on ClinicalTrials.gov |
What this trial studies
This observational study aims to recruit 500 patients with Type 2 diabetes from Fortis-CDOC Hospital in New Delhi. The study will collect various health metrics, including weight, BMI, lipid profiles, and glycemic parameters, along with socio-economic and lifestyle factors through phone interviews. The data will be analyzed using advanced machine learning and deep learning techniques to develop predictive models for diabetes management and cardiovascular risk. The analysis will also include traditional statistical methods to ensure robust findings.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Type 2 diabetes.
Not a fit: Patients with Type 1 diabetes, genetic diabetes, gestational diabetes, or terminal illnesses such as cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the prediction and management of cardiometabolic risks in Asian Indians with Type 2 diabetes.
How similar studies have performed: Other studies utilizing machine learning and AI for diabetes prediction have shown promising results, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: - T2DM Exclusion Criteria: * T1DM * Genetic Diabetes * Gestational Diabetes * Terminal Illness (Cancer)
Where this trial is running
New Delhi, Delhi
- Fortis Cdoc Hospital — New Delhi, Delhi, India (Recruiting)
Study contacts
- Study coordinator: Anoop Misra, Md
- Email: anoopmisra@gmail.com
- Phone: 01149101222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.